Results 301 to 310 of about 407,104 (349)

The relationship between insulin resistance and fibroblast growth factor 23 in patients with non-diabetic pre-dialysis chronic kidney disease: a cross-sectional study. [PDF]

Sao Paulo Med J
Durak BA, Coban M.
europepmc   +1 more source

C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.

Am J Physiol Renal Physiol
Hu MC, Reneau JA, Shi M, Takahashi M, Chen G, Mohammadi M, Moe OW.   +6 more
europepmc   +1 more source

Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice.

Endocrinology
Park MY, Tu CL, Perie L, Verma N, Serdan TDA, Shamsi F, Shapses S, Heffron S, Gamallo-Lana B, Mar AC, Alemán JO, Mueller E, Chang W, Sitara D.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibroblast growth factor 23

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2013
There is growing interest in the role of fibroblast growth factor 23 (FGF23) in various diseases of disordered mineral metabolism. In chronic kidney disease (CKD), where biochemical evidence of mineral disturbances is especially common, FGF23 measurement has been advocated as an early and sensitive marker for CKD-related bone disease. In this setting,
Edward R, Smith, Lawrence P, McMahon, Stephen G, Holt   +2 more
openaire   +2 more sources